Droia Oncology Ventures

Investor type

VC

Last fund created

2011

AUM

-

Location

Luxembourg

$1-5 m

Investment Ticket

3-5 years

Investment Horizon

Seed, Series A

Investment Stage

Sale to strategic investor, IPO

Exit Strategy

Profile

Droia invests globally in young drug development companies that use novel science and innovative approaches to bring promising therapies to patients. We are specialists, investing exclusively in therapeutics for oncology and genetic disease. Our focus and our in-house team of drug development experts and biotech professionals allow us to accelerate our companies’ progress by actively supporting them from company creation through clinical proof of concept. We are hands-on investors and entrepreneurs, fully dedicated to making an impact and saving patient lives.

Industry

Biotechnology Healthcare Services Medical Devices Pharmaceuticals SaaS Blockchain/Crypto AI MedTech Life Sciences VR/AR HealthTech

Region of investment

North America Europe Asia

Contacts

Upgrade to see contacts
Name
Title
Email
avatar
Gst3zDbFSn9NwECL Investment Partner
Investment Partner
avatar
Gst3zDbFSn9NwECL Principal
Principal
avatar
Gst3zDbFSn9NwECL Partner
Partner
avatar
Gst3zDbFSn9NwECL Principal
Principal
If there are no contacts of this investor, please write to us, we will try to find them as soon as possible and get back to you!